Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of youxinding capsules for depression
ChiCTR2400085847Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of youxinding capsules in major depressive disorder (MDD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Montgomery-Asberg Depression Rating Scale. Started Jun 2024; status: recruiting.
02
Drugs
youxinding capsules
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2400085847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085847.